Zomedica exercises option to acquire Structured Monitoring Products for $18M enterprise value

Zomedica Corp.

Exercised option to buy SMP, maker of VetGuardian remote monitoring system, at $18M enterprise value.
Paid a non-refundable $250k deposit toward the purchase price; 120-day due diligence period begins.
Zomedica invested $2.75M in convertible notes in May 2022, Jan and Mar 2023, which included this option.
VetGuardian is a zero-touch vital signs monitor; Zomedica has been distributing it since January 2023.
Deal includes a sublicense for human use rights to a NewCo entity, with royalties to University of Florida Research Foundation.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.